<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-0807</journal-id>
<journal-title><![CDATA[Revista de la Universidad Industrial de Santander. Salud]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Univ. Ind. Santander. Salud]]></abbrev-journal-title>
<issn>0121-0807</issn>
<publisher>
<publisher-name><![CDATA[Universidad Industrial de Santander]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-08072025000100027</article-id>
<article-id pub-id-type="doi">10.18273/saluduis.57.e:25v57e20</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Inequidades en la supervivencia al cáncer de pulmón, Manizales, Colombia 2008-2018: estudio de base poblacional]]></article-title>
<article-title xml:lang="en"><![CDATA[Inequities in Lung Cancer Survival, Manizales, Colombia 20082018: A Population-Based Study]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Giraldo-Osorio]]></surname>
<given-names><![CDATA[Alexandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Manrique Mendoza]]></surname>
<given-names><![CDATA[Yoan D]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Loaiza Ruiz]]></surname>
<given-names><![CDATA[Daniel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arias-Ortiz]]></surname>
<given-names><![CDATA[Nelson Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Caldas  ]]></institution>
<addr-line><![CDATA[Manizales ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>57</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-08072025000100027&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-08072025000100027&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-08072025000100027&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: El cáncer de pulmón es la principal causa de muerte por cáncer en el mundo (18% de las muertes por cáncer), y representa el 11,4% del total de cánceres.  Objetivo: Estimar la supervivencia al cáncer de pulmón según nivel socio-económico (NSE), régimen de aseguramiento en salud (RAS), y zona de residencia (ZR) en Manizales.  Metodología: Análisis de supervivencia de base poblacional a partir de los casos incidentes de cáncer de pulmón entre 2008-2018 captados por el Registro Poblacional de Cáncer de Manizales. Se calculó la supervivencia global (SG) por el método de Kaplan Meier y la asociación con variables de interés mediante modelos de Cox.  Resultados: Se analizaron 577 casos incidentes. La SG fue de 11,4% a los 60 meses, con una mediana de tiempo de supervivencia de 5,0 meses. Se observó un riesgo instantáneo de muerte 50% mayor en los pacientes del RAS subsidiado.  Discusión: En Manizales, aproximadamente 9 de cada 10 pacientes han fallecido a los cinco años del diagnóstico, cifra consistente con lo reportado en el estudio CONCORD-3. Se evidenció una menor supervivencia en pacientes del régimen subsidiado y con bajo nivel socioeconómico, lo que refleja inequidades en el acceso, en la calidad del diagnóstico y en el tratamiento del cáncer de pulmón en Manizales; situación comparable con el contexto internacional y nacional, donde los determinantes sociales podrían limitar el acceso oportuno a la atención oncológica, especialmente en personas sin capacidad de pago o con afiliación al régimen subsidiado.  Conclusiones: La SG al cáncer de pulmón en Manizales es de 9 de cada 10 pacientes fallecidos antes de los 5 años, debido al diagnóstico en estadio avanzado, edad&gt;65 años, sexo masculino, y NSE bajo. Los pacientes pertenecientes al RAS subsidiado tienen mayor riesgo de morir.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Lung cancer is the leading cause of cancer-related death worldwide, accounting for 18% of all cancer deaths and representing 11.4% of all cancer cases.  Objective: To estimate lung cancer survival according to socioeconomic status (SES), health insurance regime (HIR), and residence area (RA) in Manizales.  Methodology: Population-based survival analysis of incident lung cancer cases from 2008 to 2018 recorded by the Manizales Population-based Cancer Registry. Overall survival (OS) was calculated using the Kaplan-Meier method; associations with the variables of interest were analyzed using Cox models.  Results: There were 577 incident cases analyzed. OS was 11.4% at 60 months, with a median survival time of 5.0 months. An instantaneous risk of death was 50% higher in patients with subsidized HIR.  Discussion: In Manizales, approximately 9 out of 10 patients have died within five years of diagnosis, a figure consistent with the findings of the CONCORD-3 study. Lower survival rates were observed among patients enrolled in the subsidized health insurance scheme and those from lower socioeconomic strata, reflecting inequities in access to care, diagnostic quality, and lung cancer treatment in Manizales. This situation parallels both national and international contexts, where social determinants may hinder timely access to oncological care, particularly for individuals without the ability to pay or those affiliated with subsidized healthcare systems.  Conclusions: The OS for lung cancer in Manizales is 9 out of 10 patients who die within 5 years, due to advanced-stage diagnosis, age &gt;65 years, male sex, and low SES. Patients with subsidized HIR are at a higher risk of dying.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cáncer de Pulmón]]></kwd>
<kwd lng="es"><![CDATA[Seguro]]></kwd>
<kwd lng="es"><![CDATA[Área Urbana]]></kwd>
<kwd lng="es"><![CDATA[Clase Social]]></kwd>
<kwd lng="es"><![CDATA[Supervivencia]]></kwd>
<kwd lng="es"><![CDATA[Colombia]]></kwd>
<kwd lng="en"><![CDATA[Lung Cancer]]></kwd>
<kwd lng="en"><![CDATA[Insurance]]></kwd>
<kwd lng="en"><![CDATA[Urban Area]]></kwd>
<kwd lng="en"><![CDATA[Social Class]]></kwd>
<kwd lng="en"><![CDATA[Survivorship]]></kwd>
<kwd lng="en"><![CDATA[Colombia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sung]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Laversanne]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soerjomataram]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global cancer statistics 2020: GLO-BOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries]]></article-title>
<source><![CDATA[CA: A Cancer Journal for Clinicians]]></source>
<year>2021</year>
<volume>71</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>209-49</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piñeros]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Forman]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Descriptive epidemiology of lung cancer and current status of tobacco control measures in Central and South America]]></article-title>
<source><![CDATA[Cancer Epidemiology]]></source>
<year>2016</year>
<volume>44</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>S90-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>International Agency for Research on Cancer</collab>
<source><![CDATA[Cancer Today: Estimated number of deaths in 2018, South America, both sexes, all ages]]></source>
<year>2018</year>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Mejía]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Viola]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chamorro]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ruíz-Patiño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lung Cancer in Colombia]]></article-title>
<source><![CDATA[J Thoracic Oncology]]></source>
<year>2022</year>
<volume>17</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>953-60</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bray]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Colombet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mery]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Piñeros]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Znaor]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zanetti]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer incidence in five continents]]></source>
<year>2017</year>
<volume>XI</volume>
<publisher-name><![CDATA[IARC Sci Publ]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias-Ortiz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Betancourt]]></surname>
<given-names><![CDATA[JD.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tendencias en la incidencia y en la mortalidad por cáncer en Manizales]]></article-title>
<source><![CDATA[Colombia Medica]]></source>
<year>2022</year>
<volume>53</volume>
<numero>1</numero>
<issue>1</issue>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Redondo-Sánchez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Petrova]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Barranco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Navarro P Jiménez-Moleón]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[MJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Socio-economic inequalities in lung cancer outcomes: an overview of systematic reviews]]></article-title>
<source><![CDATA[Cancers (Basel)]]></source>
<year>2022</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>398</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Omeogu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Islam]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Joshi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Braithwaite]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Socioeconomic disparities in immunothera-py use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database]]></article-title>
<source><![CDATA[Sci Rep]]></source>
<year>2023</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hanafusa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ishibashi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nakaya]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Nawa]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sobue]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between socioeconomic status and net survival after primary lung cancer surgery: a tertiary university hospital retrospective observational study in Japan]]></article-title>
<source><![CDATA[Jpn J Clin Oncol]]></source>
<year>2023</year>
<volume>53</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>287-96</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qureshi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Boily]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Boulanger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pagé]]></surname>
<given-names><![CDATA[É]]></given-names>
</name>
<name>
<surname><![CDATA[Strumpf]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inequalities in survival and care across social determinants of health in a cohort of advanced lung cancer patients in Quebec (Canada): a high-resolution population-level analysis]]></article-title>
<source><![CDATA[Cancer Med]]></source>
<year>2023</year>
<volume>12</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>12683-704</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sahar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Douangchai Wills]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Fedewa]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenthal]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Kazerooni]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Geographic access to lung cancer screening among eligible adults living in rural and urban environments in the United States]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2022</year>
<volume>128</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1584-94</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Tyan]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Rana]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Goodridge]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hergott]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Osgood]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rural vs urban inequalities in stage at diagnosis for lung cancer]]></article-title>
<source><![CDATA[Cancer Treat Res Commun]]></source>
<year>2021</year>
<volume>29</volume>
<page-range>100495</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[L&#339;rum]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Strand]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
<name>
<surname><![CDATA[Brustugun]]></surname>
<given-names><![CDATA[OT]]></given-names>
</name>
<name>
<surname><![CDATA[Gallefoss]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Falk]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Durheim]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of sex inequity in lung-cancer-specific survival]]></article-title>
<source><![CDATA[Acta Oncol]]></source>
<year>2024</year>
<volume>63</volume>
<page-range>343-50</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pilleron]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Maringe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Charvat]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Atkinson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Morris]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sarfati]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Age disparities in lung cancer survival in New Zealand: the role of patient and clinical factors]]></article-title>
<source><![CDATA[Lung Cancer]]></source>
<year>2021</year>
<volume>157</volume>
<page-range>92-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Warren]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[Cummings]]></surname>
<given-names><![CDATA[KM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer]]></article-title>
<source><![CDATA[Am Soc Clin Oncol Educ Book]]></source>
<year>2013</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>359-64</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Carranza]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Otero]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Reveiz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Reguart]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supervivencia de pacientes con cáncer de pulmón de célula no pequeña en cuatro instituciones de Colombia]]></article-title>
<source><![CDATA[Rev Venez Oncol]]></source>
<year>2010</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>66-83</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvajal-Fierro]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[González-Hurtado]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ballén-Lozano]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Parra-Medina]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Callejas-Gutiérrez]]></surname>
<given-names><![CDATA[AM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis de supervivencia de los pacientes con cáncer de pulmón de célula no pequeña tratados en el Instituto Nacional de Cancerología de Colombia en el periodo 2018-2022]]></article-title>
<source><![CDATA[Rev Colomb Cancerol]]></source>
<year>2024</year>
<volume>28</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>149-61</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guevara]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Parody]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Aguirre]]></surname>
<given-names><![CDATA[AF.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Costo-efectividad de toracotomía versus videotoracoscopia en pacientes con cáncer de pulmón de célula no pequeña en estadio I]]></article-title>
<source><![CDATA[Rev Colomb Cir]]></source>
<year>2015</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-39</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarado-Sarzosa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Jaramillo]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[García-Herreros-Hellal]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Beltrán-Jiménez]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zuluaga-Restrepo]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Parra-Medina]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desenlaces clínicos de pacientes con cáncer de pulmón de célula no pequeña temprano manejados quirúrgicamente en Bogotá (Colombia)]]></article-title>
<source><![CDATA[Rev Colomb Cancerol]]></source>
<year>2023</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>240-50</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias-Ortiz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[López-Guarnizo]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de calidad de los datos del Registro Poblacional de Cáncer de Manizales, Colombia]]></article-title>
<source><![CDATA[Rev Colomb Cancerol]]></source>
<year>2013</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>132-41</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud y Protección Social</collab>
<source><![CDATA[Guía de práctica clínica para la detección temprana, diagnóstico, esta dificación y tratamiento del cáncer de pulmón]]></source>
<year>2014</year>
<page-range>1-112</page-range><publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud y Protección Social]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<collab>Red Europea de Registros de Cáncer (ENCR)</collab>
<source><![CDATA[Recomendaciones ENCR. Codificación de la fecha de incidencia]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud</collab>
<source><![CDATA[Resolución 8430 de 1993]]></source>
<year>1993</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allemani]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Matsuda]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Di Carlo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Harewood]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Matz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Niksic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37,5I3,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 7I countries]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2018</year>
<volume>391</volume>
<numero>10125</numero>
<issue>10125</issue>
<page-range>1023-75</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casal-Mouriño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ruano-Ravina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo-González]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Martínez]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Giraldo-Osorio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Varela-Lema]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival]]></article-title>
<source><![CDATA[Transl Lung Cancer Res]]></source>
<year>2021</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>506-18</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Niu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Roche]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Pawlish]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Henry]]></surname>
<given-names><![CDATA[KA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer survival disparities by health insurance status]]></article-title>
<source><![CDATA[Cancer Med]]></source>
<year>2013</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>403-11</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chayo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Uribe Perez]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[de Vries]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pinheiro]]></surname>
<given-names><![CDATA[PS.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of health insurance affiliation and socioeconomic status on cervical cancer survival in Bucaramanga, Colombia]]></article-title>
<source><![CDATA[Cancer Epidemiol]]></source>
<year>2023</year>
<volume>85</volume>
<page-range>102375</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias-Ortiz]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[de Vries]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Health inequities and cancer survival in Manizales, Colombia: a population-based study]]></article-title>
<source><![CDATA[Colomb Med]]></source>
<year>2018</year>
<volume>49</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>63-72</page-range><publisher-loc><![CDATA[Cali ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias-Ortiz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Betancourt]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Toro-Toro]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro-Lechuga]]></surname>
<given-names><![CDATA[É]]></given-names>
</name>
<name>
<surname><![CDATA[Jurado-Fajardo]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Cárdenas-Garzón]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of health inequities on population-based breast cancer survival in a Colombian population, 2008-2015]]></article-title>
<source><![CDATA[Cancer Control]]></source>
<year>2024</year>
<volume>31</volume>
<numero>48</numero>
<issue>48</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hartley-Blossom]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona-Del Valle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Muns-Aponte]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Udayakumar]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Carlos]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Flores]]></surname>
<given-names><![CDATA[EJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Advancing health equity in lung cancer screening and the role of humanomics]]></article-title>
<source><![CDATA[Thorac Surg Clin]]></source>
<year>2023</year>
<volume>33</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>365</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="book">
<collab>Secretaría de Salud Pública de Manizales</collab>
<source><![CDATA[Análisis de situación de salud: transición entre el modelo de los determinantes sociales de salud y el modelo participativo]]></source>
<year>2023</year>
<page-range>1-161</page-range><publisher-loc><![CDATA[Manizales ]]></publisher-loc>
<publisher-name><![CDATA[Dirección Territorial de Salud de Caldas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parsons]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Daley]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Begh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Aveyard]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2010</year>
<volume>340</volume>
<numero>7740</numero>
<issue>7740</issue>
<page-range>251</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[YT]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[YH]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[YP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stage shift improves lung cancer survival: real-world evidence]]></article-title>
<source><![CDATA[J Thorac Oncol]]></source>
<year>2023</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>47-56</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[GF]]></given-names>
</name>
<name>
<surname><![CDATA[Amaya]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Buitrago]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Attributable costs of lung cancer for the Colombian health system: a cost-of-illness study]]></article-title>
<source><![CDATA[Value Health Reg Issues]]></source>
<year>2022</year>
<volume>30</volume>
<page-range>120-6</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Collazos P Ramírez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Carrascal]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Nuñez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cali cancer registry methods]]></article-title>
<source><![CDATA[Colombia Médica]]></source>
<year>2018</year>
<volume>49</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>109-20</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Houssein]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of cancer data and survival estimates: a review of literature]]></article-title>
<source><![CDATA[Series Clin Med Case Rep Rev]]></source>
<year>2024</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda-Filho]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Uribe-Perez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Arias-Ortiz]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Yépez-Chamorro]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of the management and proportion of lost to follow-up cases on cancer survival estimates for small population-based cancer registries]]></article-title>
<source><![CDATA[J Cancer Epidemiol]]></source>
<year>2022</year>
<page-range>1</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
